Search by Drug Name or NDC

    NDC 68084-0244-01 Clindamycin Hydrochloride 300 mg/1 Details

    Clindamycin Hydrochloride 300 mg/1

    Clindamycin Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is CLINDAMYCIN HYDROCHLORIDE.

    Product Information

    NDC 68084-0244
    Product ID 68084-244_07e99cc8-b180-e825-e063-6394a90a10d0
    Associated GPIs 16220020100120
    GCN Sequence Number 009340
    GCN Sequence Number Description clindamycin HCl CAPSULE 300 MG ORAL
    HIC3 W1K
    HIC3 Description LINCOSAMIDE ANTIBIOTICS
    GCN 40832
    HICL Sequence Number 004044
    HICL Sequence Number Description CLINDAMYCIN HCL
    Brand/Generic Generic
    Proprietary Name Clindamycin Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clindamycin Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name CLINDAMYCIN HYDROCHLORIDE
    Labeler Name American Health Packaging
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065061
    Listing Certified Through 2024-12-31

    Package

    NDC 68084-0244-01 (68084024401)

    NDC Package Code 68084-244-01
    Billing NDC 68084024401
    Package 100 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-244-01) / 1 CAPSULE in 1 BLISTER PACK (68084-244-11)
    Marketing Start Date 2008-04-30
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.21042
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description CLINDAMYCIN HCL 300 MG CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis